UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

APTT reagent with ellagic acid as activator shows adequate lupus anticoagulant sensitivity in comparison to silica‐based reagent

Journal of thrombosis and haemostasis, 2012-11, Vol.10 (11), p.2338-2343

2012

Volltextzugriff (PDF)

Rapid remission of severe pain from livedoid vasculopathy by apixaban

Journal of the European Academy of Dermatology and Venereology, 2017-01, Vol.31 (1), p.e45-e46

2017

Volltextzugriff (PDF)

Index of circulating anticoagulant cut‐off value establishment in activated partial thromboplastin time mixing test for lupus anticoagulant diagnosis

Journal of thrombosis and haemostasis, 2013-10, Vol.11 (10), p.1919-1922

2013

Volltextzugriff (PDF)

The production of coagulation factor VII by adipocytes is enhanced by tumor necrosis factor-α or isoproterenol

International Journal of Obesity, 2015-05, Vol.39 (5), p.747-754

2015

Volltextzugriff (PDF)

Trousseau’s syndrome associated with tissue factor produced by pulmonary adenocarcinoma

Thorax, 2006-11, Vol.61 (11), p.1009-1010

2006

Volltextzugriff (PDF)

Synthetic selective inhibitors of coagulation factor Xa strongly inhibit thrombin generation without affecting initial thrombin forming time necessary for platelet activation in hemostasis

Journal of thrombosis and haemostasis, 2004-04, Vol.2 (4), p.612-618

2004

Volltextzugriff (PDF)

PB1168 Correlations between Concentrations and Anticoagulant Effects are Different among Direct Oral Anticoagulants Administered to Patients

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.100956, Article 100956

2023

Volltextzugriff (PDF)

In Vitro Expansion of Human Peripheral Blood CD34+ Cells

Blood, 1993-12, Vol.82 (12), p.3600-3609

1993

Volltextzugriff (PDF)

Clinical features of 32 new Japanese cases with autoimmune haemorrha-philia due to anti-factor XIII antibodies

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-09, Vol.21 (5), p.653-658

2015

Volltextzugriff (PDF)

The production of coagulation factor VII by adipocytes is enhanced by tumor necrosis factor-[alpha] or isoproterenol

International Journal of Obesity, 2015-05, Vol.39 (5), p.747

2015

Volltextzugriff (PDF)

Microparticles and Nucleosomes Are Released From Parenchymal Cells Destroyed After Injury in a Rat Model of Blunt Trauma

Clinical and applied thrombosis/hemostasis, 2020, Vol.26, p.1076029620950825-1076029620950825

2020

Volltextzugriff (PDF)

Multiple thromboses in major arteries in a patient with antiphospholipid syndrome associated with excess of a large multimer of von Willebrand factor

Lupus, 2001-12, Vol.10 (12), p.895-896

2001

Volltextzugriff (PDF)

As many as 12 cases with haemorrhagic acquired factor XIII deficiency due to its inhibitors were recently found in Japan

Thrombosis and haemostasis, 2011-05, Vol.105 (5), p.925-927

2011

Volltextzugriff (PDF)

Inhibitors of Factor XIII/13 in older patients

Seminars in thrombosis and hemostasis, 2014-09, Vol.40 (6), p.704-711

Ichinose, Akitada

2014

Volltextzugriff (PDF)

Treatment of bleeding in acquired hemophilia A with the proper administration of recombinant activated factor VII: single-center study of 7 cases

International journal of general medicine, 2016-01, Vol.9, p.393-399

2016

Volltextzugriff (PDF)

Susceptibility of brain microvascular endothelial cells to advanced glycation end products-induced tissue factor upregulation is associated with intracellular reactive oxygen species

Brain research, 2006-09, Vol.1108 (1), p.179-187

2006

Volltextzugriff (PDF)

Suppressed intrinsic fibrinolytic activity by monoclonal anti‐beta‐2 glycoprotein I autoantibodies: possible mechanism for thrombosis in patients with antiphospholipid syndrome

British journal of haematology, 2002-12, Vol.119 (3), p.781-788

2002

Volltextzugriff (PDF)

The inhibition of protein C anticoagulant activity by anti-β2-glycoprotein I (β2GPI) antibodies isolated from patients with antiphospholipid syndrome by chromatography methods

Modern rheumatology, 2002-03, Vol.12 (1), p.44-49

2002

Volltextzugriff (PDF)

Disseminated intravascular coagulation at an early phase of trauma is associated with consumption coagulopathy and excessive fibrinolysis both by plasmin and neutrophil elastase

Surgery, 2011-02, Vol.149 (2), p.221-230

2011

Volltextzugriff (PDF)

Factor Xa inhibitors: new anti-thrombotic agents and their characteristics

Frontiers in bioscience, 2006-01, Vol.11 (1), p.232

2006

Volltextzugriff (PDF)

Role of cytokines in leukemic type growth of myelodysplastic CD34+ cells

Blood, 1996-07, Vol.88 (1), p.319-327

1996

Volltextzugriff (PDF)

Transitional change of colony stimulating factor requirements for erythroid progenitors

Journal of cellular physiology, 1991-10, Vol.149 (1), p.1-8

1991

Volltextzugriff (PDF)

Subclinical Alterations in Coagulation and Fibrinolysis in Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation

Leukemia & lymphoma, 1998, Vol.28 (3-4), p.405-413

1998

Volltextzugriff (PDF)

Protein C Sapporo (protein C Glu 25 --> Lys): a heterozygous missense mutation in the Gla domain provides new insight into the interaction between protein C and endothelial protein C receptor

Thrombosis and haemostasis, 2005-11, Vol.94 (5), p.942-950

2005

Volltextzugriff (PDF)

Protection by α2‐macroglobulin of tissue plasminogen activator against inhibition by plasminogen activator inhibitor‐1

British journal of haematology, 1997-04, Vol.97 (1), p.214-218

1997

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Aktive Filter

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(59)
Berichte
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(32)
Science & Technology
(32)
Humans
(31)
Biological And Medical Sciences
(21)
Hematology
(21)
Medical Sciences
(18)
Female
(14)
Male
(14)
Adult
(13)
Middle Aged
(12)
Aged
(9)
Hematologic And Hematopoietic Diseases
(9)
Cardiovascular System & Cardiology
(8)
Peripheral Vascular Disease
(8)
Beta 2-Glycoprotein I
(7)
Animals
(6)
Recombinant Proteins - Pharmacology
(6)
Blood Coagulation
(5)
Cells, Cultured
(5)
Platelet Diseases And Coagulopathies
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

APTT reagent with ellagic acid as activator shows adequate lupus anticoagulant sensitivity in comparison to silica‐based reagent

Rapid remission of severe pain from livedoid vasculopathy by apixaban

Index of circulating anticoagulant cut‐off value establishment in activated partial thromboplastin time mixing test for lupus anticoagulant diagnosis

The production of coagulation factor VII by adipocytes is enhanced by tumor necrosis factor-α or isoproterenol

Trousseau’s syndrome associated with tissue factor produced by pulmonary adenocarcinoma

Synthetic selective inhibitors of coagulation factor Xa strongly inhibit thrombin generation without affecting initial thrombin forming time necessary for platelet activation in hemostasis

PB1168 Correlations between Concentrations and Anticoagulant Effects are Different among Direct Oral Anticoagulants Administered to Patients

In Vitro Expansion of Human Peripheral Blood CD34+ Cells

Clinical features of 32 new Japanese cases with autoimmune haemorrha-philia due to anti-factor XIII antibodies

The production of coagulation factor VII by adipocytes is enhanced by tumor necrosis factor-[alpha] or isoproterenol

Microparticles and Nucleosomes Are Released From Parenchymal Cells Destroyed After Injury in a Rat Model of Blunt Trauma

Multiple thromboses in major arteries in a patient with antiphospholipid syndrome associated with excess of a large multimer of von Willebrand factor

As many as 12 cases with haemorrhagic acquired factor XIII deficiency due to its inhibitors were recently found in Japan

Inhibitors of Factor XIII/13 in older patients

Treatment of bleeding in acquired hemophilia A with the proper administration of recombinant activated factor VII: single-center study of 7 cases

Susceptibility of brain microvascular endothelial cells to advanced glycation end products-induced tissue factor upregulation is associated with intracellular reactive oxygen species

Suppressed intrinsic fibrinolytic activity by monoclonal anti‐beta‐2 glycoprotein I autoantibodies: possible mechanism for thrombosis in patients with antiphospholipid syndrome

The inhibition of protein C anticoagulant activity by anti-β2-glycoprotein I (β2GPI) antibodies isolated from patients with antiphospholipid syndrome by chromatography methods

Disseminated intravascular coagulation at an early phase of trauma is associated with consumption coagulopathy and excessive fibrinolysis both by plasmin and neutrophil elastase

Factor Xa inhibitors: new anti-thrombotic agents and their characteristics

Role of cytokines in leukemic type growth of myelodysplastic CD34+ cells

Transitional change of colony stimulating factor requirements for erythroid progenitors

Subclinical Alterations in Coagulation and Fibrinolysis in Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation

Protein C Sapporo (protein C Glu 25 --> Lys): a heterozygous missense mutation in the Gla domain provides new insight into the interaction between protein C and endothelial protein C receptor

Protection by α2‐macroglobulin of tissue plasminogen activator against inhibition by plasminogen activator inhibitor‐1

Aktive Filter

Suchergebnisse filtern